This study aimed to investigate the effects of duloxetine and pregabalin primarily on pain and functional status in patients with knee osteoarthritis and secondarily on quality of life, depression, anxiety, and sleep disturbance. A total of 66 patients with knee osteoarthritis were randomized to use duloxetine or pregabalin. Patients were evaluated by Visual Analog Scale, Neuropathic Pain Diagnostic Questionnaire, Western Ontario and McMaster University Osteoarthritis Index, Short Form-36, Beck Depression Inventory, Beck Anxiety Inventory, and Pittsburg Sleep Quality Index before the treatment and after 4 and 12 weeks of treatment. Improvements occurred in Visual Analog Scale, Neuropathic Pain Diagnostic Questionnaire, Western Ontario and McMaster University Osteoarthritis Index, Short Form-36 (with an exception of the mental health subgroup scores in duloxetine-treated group), Beck Depression Inventory, and Beck Anxiety Inventory scores in both groups from 4 weeks after baseline. Pittsburg Sleep Quality Index total scores and SF-36 mental health subgroup scores started to improve on the 4th and 12th weeks in pregabalin- and duloxetine-treated groups, respectively. Osteoarthritis pain, a complex outcome with nociceptive and neuropathic components, leads to central sensitization in a chronic phase. Using centrally acting drugs in the control of pain and associated symptoms would increase the probability of treatment success.
1 December 2021 in Turkish Journal of Physical Medicine and Rehabilitation
Pregabalin is commonly used for the treatment of neuropathic pain and is attributed to adverse effects of peripheral vasodilation and peripheral edema. Central serous chorioretinopathy (CSCR) is characterized by choroidal fluid leaks from choroidal vessels under the retina, causing focal retinal detachment with macular vision loss. Herein, we report two cases admitted to our clinic with vision loss while under pregabalin treatment. Upon eye examination, both patients were diagnosed with acute CSCR. Pregabalin treatment was discontinued upon the diagnosis of CSCR. We consider that the use of pregabalin in the presented two cases may be the causal effect of the CSCR diagnosis, as pathophysiology of CSCR is in parallel with the edema-related adverse effects of pregabalin.
Rationale: Neurogenic pectoralis minor syndrome (NPMiS) is an underdiagnosed cause of persistent neck, shoulder, and upper extremity pain. It can mimic cervical radiculopathy or other musculoskeletal disorders, often resulting in misdiagnosis and ineffective treatment. This case series presents 5 patients with NPMiS who achieved symptomatic relief through diagnostic ultrasound-guided pectoralis minor muscle (PMiM) block followed by targeted rehabilitation. Patient concerns: All patients presented with persistent neck pain often radiating to the scapula or anterior chest wall, along with paresthesia and impaired sleep quality. Prior treatments, including non-steroidal anti-inflammatory drugs, muscle relaxants, and physical therapy, were ineffective. One patient was referred for spine surgery before alternative evaluation. Diagnoses: The diagnosis of NPMiS was based on detailed clinical history, positive physical exam findings (e.g., Roos test, focal PMiM tenderness), and exclusion of cervical radiculopathy and peripheral neuropathies via imaging and electrophysiological studies. Confirmatory diagnosis was established with significant symptom relief following ultrasound-guided PMiM block. Interventions: Patients received diagnostic ultrasound-guided injection of 1% lidocaine into the PMiM. This was followed by an individualized rehabilitation program including posture correction, ergonomic adjustments, and physical therapy focused on pectoral muscle stretching and shoulder stabilization. Outcomes: Patients experienced rapid pain reduction, improved function, reduced medication use, and better sleep. Sustained symptom relief was achieved through adherence to rehabilitation. Lessons: NPMiS should be considered in the differential diagnosis of chronic, non-dermatomal neck and upper extremity pain, particularly when standard treatments fail. Ultrasound-guided PMiM block is a valuable tool both for confirming diagnosis and initiating effective, personalized therapy strategies.
To evaluate the relationship between ultrasound (US) findings and radiographic Kellgren–Lawrence (K/L) grades, symptom severity, and the presence of generalized osteoarthritis (GOA) in patients with knee osteoarthritis (OA), and to identify key US parameters associated with OA severity. This cross-sectional study included 166 patients (332 knees) with radiographically confirmed knee OA. US assessments included medial and lateral meniscus extrusion (MME, LME), suprapatellar effusion, synovitis, femoral cartilage thickness (FCT), femoral cartilage lesions, Baker's cyst, pes anserine bursitis, patellar tendinopathy, and Hoffa's fat pad pathology. K/L grades were determined by radiography. Pain and function were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). GOA was defined as OA in five or more joints or the presence of Heberden's nodes with additional joint involvement. MME showed a strong correlation with K/L grade (r = 0.954, p < 0.001), with 91.57 % exact agreement. LME showed a moderate correlation (r = 0.693, p < 0.001). GOA was identified in 12.65 % of patients and was independently associated with lower BMI, reduced FCT (<2 mm), and the presence of femoral cartilage lesions. Moderate correlations were observed between K/L grade and pain, WOMAC scores, and symptom duration. MME and FCT measured by US are strong indicators of OA severity and may help identify patients at risk for GOA. US appears to be a practical, radiation-free tool for assessing and monitoring OA progression. Further validation in larger cohorts is recommended.
8 May 2026 in Movement Disorders Clinical Practice